MLKL and liver disorder: To analyze the clinical relevance of necroptotic mediators in liver transplantation and end-stage liver diseases, immunohistochemistry was performed on consecutive liver slices using validated RIPK318,19 and phosphorylated mixed lineage kinase domain-like (pMLKL)20,21 antibodies.